SV2A antibody
Principal name
SV2A antibody
Alternative names for SV2A antibody
Synaptic vesicle glycoprotein 2A, KIAA0736
Ncbi ID
9606, NP_055664, ACE87176.1, NP_055664.3, NP_071313.1, NM_022030, NM_057210
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of SV2A antibody
- Kit Component:
- - KN317010G1, Sv2a gRNA vector 1 in pCas-Guide vector
- KN317010G2, Sv2a gRNA vector 2 in pCas-Guide vector
- KN317010D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Gregory,S.G., (2006) Nature 441 (7091), 315-321

SV2A polyclonal antibody ( Cat # PAB7115 ) ( 0.3 µg/ml ) staining of rat brain lysate ( 35 µg protein in RIPA buffer ) . Primary incubation was 1 hour. Detected by chemiluminescence.

Human Brain; WB Suggested Anti-SV2A Antibody Titration: 0.2-1 ug/ml. Positive Control: Human brain; SV2A antibody - middle region (ARP47093_P050) in Human Brain cells using Western Blot

TA303147 (0.3µg/ml) staining of rat brain lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Predicted cell location: Cytoplasm . Positive control: Human liver and lung cancer tissue . Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human liver cancer tissue using SV2A antibody at dilution 1/25, on the right is treated with the synthetic peptide. (Original magnification:x 200)

Predicted cell location: Cytoplasm . Positive control: Human liver and lung cancer tissue . Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human lung cancer tissue using SV2A antibody at dilution 1/25, on the right is treated with the synthetic peptide. (Original magnification:x200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA303147 | SV2A antibody |
||||||
| Goat Polyclonal Antibody against SV2A | |||||||
![]() |
Goat | Aff - Purified | Can, Hu, Ms, Rt | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA322365 | SV2A antibody |
||||||
| Anti-SV2A Rabbit Polyclonal Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA590527 | SV2A antibody |
||||||
| Rabbit Polyclonal SV2A Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E |
0.1 mg /
€409.00
|
|
| OriGene Technologies, Inc. | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210408L2V | Lenti ORF particles, Sv2a (GFP-tagged) - Mouse synaptic vesicle glycoprotein 2 a (Sv2a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,530.00
|
|
| OriGene Technologies, Inc. | ||
| MR210408L1V | Lenti ORF particles, Sv2a (Myc-DDK-tagged) - Mouse synaptic vesicle glycoprotein 2 a (Sv2a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,370.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR209600L2V | Lenti ORF particles, Sv2a (GFP-tagged ORF) - Rat synaptic vesicle glycoprotein 2a (Sv2a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,530.00
|
|
| OriGene Technologies, Inc. | ||
| RR209600L1V | Lenti ORF particles, Sv2a (Myc-DDK-tagged ORF) - Rat synaptic vesicle glycoprotein 2a (Sv2a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,370.00
|
|
| OriGene Technologies, Inc. | ||




+1 additional image
